Allergy Therapeutics plc (AGY.L)
GBp 6.45
(2.38%)
GBp 6.45
(2.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 21.14 Million GBP | 311.74% |
| 2021 | -9.98 Million GBP | 65.69% |
| 2020 | -29.1 Million GBP | -17.42% |
| 2019 | -24.78 Million GBP | 0.88% |
| 2018 | -25 Million GBP | -100.43% |
| 2017 | -12.47 Million GBP | 33.63% |
| 2016 | -18.79 Million GBP | 6.22% |
| 2015 | -20.04 Million GBP | -2.7% |
| 2014 | -19.51 Million GBP | -885.61% |
| 2013 | -1.98 Million GBP | -104.33% |
| 2012 | -969 Thousand GBP | -256.29% |
| 2011 | 620 Thousand GBP | -95.6% |
| 2010 | 14.1 Million GBP | 96.33% |
| 2009 | 7.18 Million GBP | -76.75% |
| 2008 | 30.9 Million GBP | 31.31% |
| 2007 | 23.53 Million GBP | 765.83% |
| 2006 | -3.53 Million GBP | 85.18% |
| 2005 | -23.86 Million GBP | -63.15% |
| 2004 | -14.62 Million GBP | -4807.72% |
| 2003 | -298 Thousand GBP | -135.56% |
| 2002 | 838 Thousand GBP | -90.64% |
| 2001 | 8.95 Million GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -3.67 Million GBP | 0.0% |
| 2022 FY | 21.14 Million GBP | 311.74% |
| 2022 Q4 | 21.14 Million GBP | 0.0% |
| 2022 Q2 | -5.42 Million GBP | 0.0% |
| 2021 FY | -9.98 Million GBP | 65.69% |
| 2021 Q2 | -31.45 Million GBP | 0.0% |
| 2021 Q4 | -9.98 Million GBP | 0.0% |
| 2020 Q2 | -36.29 Million GBP | 0.0% |
| 2020 FY | -29.1 Million GBP | -17.42% |
| 2020 Q4 | -29.1 Million GBP | 0.0% |
| 2019 FY | -24.78 Million GBP | 0.88% |
| 2019 Q4 | -24.78 Million GBP | 0.0% |
| 2019 Q2 | -28.75 Million GBP | 0.0% |
| 2018 Q2 | -28.88 Million GBP | 0.0% |
| 2018 Q4 | -25 Million GBP | 0.0% |
| 2018 FY | -25 Million GBP | -100.43% |
| 2017 Q4 | -12.47 Million GBP | 0.0% |
| 2017 FY | -12.47 Million GBP | 33.63% |
| 2017 Q2 | -22.61 Million GBP | 0.0% |
| 2016 Q4 | -18.79 Million GBP | 0.0% |
| 2016 FY | -18.79 Million GBP | 6.22% |
| 2016 Q2 | -24.38 Million GBP | 0.0% |
| 2015 Q4 | -20.04 Million GBP | 0.0% |
| 2015 FY | -20.04 Million GBP | -2.7% |
| 2015 Q2 | -31.56 Million GBP | 0.0% |
| 2014 Q4 | -19.51 Million GBP | 0.0% |
| 2014 Q2 | -7.93 Million GBP | 0.0% |
| 2014 FY | -19.51 Million GBP | -885.61% |
| 2013 Q2 | -5.11 Million GBP | 0.0% |
| 2013 FY | -1.98 Million GBP | -104.33% |
| 2013 Q4 | -1.98 Million GBP | 0.0% |
| 2012 Q4 | -969 Thousand GBP | 22.91% |
| 2012 Q3 | -1.25 Million GBP | 61.93% |
| 2012 Q2 | -3.3 Million GBP | 0.0% |
| 2012 FY | -969 Thousand GBP | -256.29% |
| 2011 FY | 620 Thousand GBP | -95.6% |
| 2011 Q2 | 7.41 Million GBP | 0.0% |
| 2011 Q4 | -806 Thousand GBP | 0.0% |
| 2010 Q2 | 8.36 Million GBP | 0.0% |
| 2010 FY | 14.1 Million GBP | 96.33% |
| 2010 Q4 | 14.1 Million GBP | 0.0% |
| 2009 Q2 | 7.12 Million GBP | 0.0% |
| 2009 FY | 7.18 Million GBP | -76.75% |
| 2009 Q4 | 7.18 Million GBP | 0.0% |
| 2008 Q4 | 30.9 Million GBP | 0.0% |
| 2008 FY | 30.9 Million GBP | 31.31% |
| 2008 Q2 | 30.29 Million GBP | 0.0% |
| 2007 Q4 | 23.53 Million GBP | 0.0% |
| 2007 FY | 23.53 Million GBP | 765.83% |
| 2007 Q2 | 9.87 Million GBP | 0.0% |
| 2006 Q2 | -15.2 Million GBP | 0.0% |
| 2006 FY | -3.53 Million GBP | 85.18% |
| 2006 Q4 | -3.53 Million GBP | 0.0% |
| 2005 Q4 | -23.86 Million GBP | 0.0% |
| 2005 Q2 | -10.91 Million GBP | 0.0% |
| 2005 FY | -23.86 Million GBP | -63.15% |
| 2004 Q2 | -17.23 Million GBP | 0.0% |
| 2004 Q4 | -14.62 Million GBP | 0.0% |
| 2004 FY | -14.62 Million GBP | -4807.72% |
| 2003 Q2 | -3.16 Million GBP | 0.0% |
| 2003 FY | -298 Thousand GBP | -135.56% |
| 2003 Q4 | -298 Thousand GBP | 0.0% |
| 2002 FY | 838 Thousand GBP | -90.64% |
| 2001 FY | 8.95 Million GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|